Timothy T. Richards's most recent trade in ClearPoint Neuro Inc was a trade of 222 Common Stock done at an average price of $17.8 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 17.84 per share. | 01 Jul 2026 | 222 | 87,544 (0%) | 0% | 17.8 | 3,960 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 04 Jun 2026 | 500 | 87,698 (0%) | 0% | 10 | 5,000 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 500 | 0 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. | 04 Jun 2026 | 376 | 87,322 (0%) | 0% | 13.3 | 5,001 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Sale of securities on an exchange or to another person at price $ 12.17 per share. | 01 Jun 2026 | 5,415 | 87,198 (0%) | 0% | 12.2 | 65,901 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 12,820 | 12,820 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2026 | 12,417 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2026 | 12,417 | 92,613 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 9.10 per share. | 01 Apr 2026 | 442 | 80,196 (0%) | 0% | 9.1 | 4,022 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 13.68 per share. | 02 Jan 2026 | 884 | 79,754 (0%) | 0% | 13.7 | 12,093 | Common Stock |
| ClearPoint Neuro Inc | Richards Timothy T. | Director | Grant, award, or other acquisition of securities at price $ 21.79 per share. | 01 Oct 2025 | 555 | 78,870 (0%) | 0% | 21.8 | 12,093 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 11.94 per share. | 01 Jul 2025 | 934 | 78,315 (0%) | 0% | 11.9 | 11,152 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 10 Jun 2025 | 10,000 | 77,381 (0%) | 0% | 13.3 | 132,800 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,417 | 12,417 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 21,093 | 87,381 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 21,093 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 11.89 per share. | 01 Apr 2025 | 938 | 66,288 (0%) | 0% | 11.9 | 11,153 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 15.38 per share. | 02 Jan 2025 | 725 | 65,350 (0%) | 0% | 15.4 | 11,151 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 11.21 per share. | 01 Oct 2024 | 995 | 64,625 (0%) | 0% | 11.2 | 11,154 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 01 Jul 2024 | 2,069 | 63,630 (0%) | 0% | 5.4 | 11,152 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 21,093 | 21,093 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 61,561 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 6.80 per share. | 01 Apr 2024 | 1,640 | 44,408 (0%) | 0% | 6.8 | 11,152 | Common Stock |
| ClearPoint Neuro Inc | Richards T. Timothy | Director | Grant, award, or other acquisition of securities at price $ 6.79 per share. | 02 Jan 2024 | 1,643 | 42,768 (0%) | 0% | 6.8 | 11,156 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 7.24 per share. | 03 Jul 2023 | 1,540 | 38,899 (0%) | 0% | 7.2 | 11,150 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 17,153 | 17,153 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 8.44 per share. | 03 Apr 2023 | 1,321 | 37,359 (0%) | 0% | 8.4 | 11,149 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 7.97 per share. | 03 Jan 2023 | 1,399 | 36,038 (0%) | 0% | 8.0 | 11,150 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 10.19 per share. | 03 Oct 2022 | 1,094 | 34,639 (0%) | 0% | 10.2 | 11,148 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 12.63 per share. | 01 Jul 2022 | 883 | 33,545 (0%) | 0% | 12.6 | 11,152 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,269 | 32,662 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 6,179 | 6,179 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 9.96 per share. | 01 Apr 2022 | 1,120 | 23,393 (0%) | 0% | 10.0 | 11,155 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 11.54 per share. | 01 Jan 2022 | 644 | 22,273 (0%) | 0% | 11.5 | 7,432 | Common Stock |
| ClearPoint Neuro Inc | Timothy T. Richards | Director | Grant, award, or other acquisition of securities at price $ 17.92 per share. | 01 Oct 2021 | 414 | 21,629 (0%) | 0% | 17.9 | 7,419 | Common Stock |